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III.     ABSTRACT        
  
The title of the research project is the ‘identification of bacteriocin produced by Klebsiella 
pneumoniae’.       
In the experiment two different strains of K. pneumoniae were used; a bacteriocin producer 
strain K. pneumoniae 957 and a bacteriocin sensitive strain K. pneumoniae 757. The aim 
of this project was to isolate the bacteriocin so it could be identified by mass spectrometry.      
The release of proteins in the cell lysate was confirmed by carrying out SDS poly 
acrylamide gel electrophoresis and the presence of bacteriocin was confirmed by bio assay 
test plate which showed the inhibition of growth of K. pneumoniae 757 by K. pneumoniae 
957 cell lysate. To isolate the bacteriocin, native PAGE was used and for identification of 
the protein band on the gel bio assay test was performed.       
The protein was isolated by ion exchange chromatography and identified by 
Mass/Spectrometry. BLAST search was used for finding the homologous peptide 
sequence.  The search result directed towards new bacteriocin produced by K. pneumoniae. 
According to the BLAST search results the bacteriocin has similarities with cloacin and 
colicin, produced by Enterobacter cloacae and Escherichia coli respectively. Both 
bacteriocins are ribonuclease.      
This new finding leads to many possible areas for exploring the similarities between 
cloacin and the new bacteriocin. To this stage new bacteriocin uses the same cell surface 
receptor for attachment and has a very similar cytotoxic domain and receptor binding 
domain that means the killing mechanism is the same as cloacin. But it is unknown if the 
victim is rRNA or tRNA, e.g., colicins E4 and E6 have sequence homology with colicin 
E3 but the E4 and E6 target amino acid incorporation and E3 directly cleaves 16s rRNA 
(Tomita et al, 2000). Therefore, if new bacteriocin has sequence homology with cloacin, 
it can have a different mechanism of action inside the sensitive cell for degrading RNA or 
it can have a different process of synthesis. All these facts can be used in future works to 
find out more about the new bacteriocin.  
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1.   Klebsiella pneumoniae      
K. pneumoniae are Gram-negative rods. They are non-motile and encapsulated. They 
contain two types of antigen in their cell surfaces that contribute to the pathogenicity; O 
and K. O antigen is a component of lipopolysaccharide there are 9 types whereas K antigen 
is present in the capsule that is polysaccharide and there are about 77 types. K. pneumoniae 
causes infection in humans, mainly in urinary tract and respiratory tract (Struve et al, 2004) 
and they are well known for hospital acquired infections (Podschun et al, 1994) because 
they cause infections in immunocompromised patients (Podschun et al, 1994). The 
bacteria colonise the human gut and spread to other sites from the gut. They are also known 
to cause septicaemia and soft tissue infections (Podschun et al, 1994). K. pneumoniae 
produce extended spectrum beta lactamase enzyme (Podschun et al, 1994; Struve et al, 
2004). Plasmid encodes gene for this enzyme and it is believed that plasmid is acquired 
from the other members of the Enterobacteriaceae spp. Strains that carry the plasmid 
become resistant to penicillin, cephalosporin, cefotaxime etc. (Struve et al, 2004).     
1.1.1.   Bacteriocins      
Bacteriocins are water soluble antimicrobial proteins synthesized by ribosomes, they are 
secreted by the bacterial cell in extracellular medium (Liu et al, 2013; Cotter et al, 2013; 
Mc Caughey et al, 2014; Ghrairi et al, 2014). Their bactericidal activity is against closely 
related species only. This inhibitory activity is a way through which they control and 
compete with the population of closely related species of bacteria (Nascimento et al, 2004). 
The production of bacteriocin is a tool for bacteria to survive in conditions of stress and 
competing against other bacteria of the same species during depletion of nutrition (Zeth, 
2012). Bacteriocins are of various forms such as low molecular weight, high molecular 
weight and phage tail like structures.         
Based on the molecular weight there are two groups of bacteriocins; low molecular weight     
(LMW) and high molecular weight bacteriocins (HMW) (Dykes GA, 1995; Daw et al,  
1996; Liu et al, 2013). Some of the low molecular weight bacteriocins are mutacins from     
Streptococcus mutans (Hamada et al, 1975) with molecular weight of 3.244 kDa (Novak 
et al, 1994) and plantaricin from Lactobacillus plantarum (Messi et al, 2001) with 
molecular weight of 3.553 kDa (Hu M et al, 2013). The high molecular weight bacteriocins 
are colicins from E. coli with molecular weight ranging from 40-80 kDa (Cascales et al, 
2007), pyocin from Pseudomonas aeruginosa with molecular weight ranging from 19 kDa 
to 85 kDa and enterocoliticin from Yersinia enterocolitica.      
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Y. enterocolitica and Stenotrophomonas maltophilia produces a phage tail like bacteriocin 
known as enterocoliticin and Maltocin P28 (Damasko et al, 2005; Liu et al, 2013). These 
are high molecular weight bacteriocins, and they kill the susceptible closely related species 
by attaching on the surface of the cell, then contracts the tail and forms a pore. The pore 
formation leads to rapid loss of ions and cell death (Strauch, et al, 2001; Damasko et al, 
2005). Phage tail like bacteriocins are like bacteriophages in morphology but unlike 
bacteriophages they cannot replicate inside the host cells. In a research study, it was 
observed that addition of enterocoliticin to Y. enterocolitica culture, reduced the 
population of live cells in 60 minutes (Damasko et al, 2005). Some of the Gram-negative 
bacteria that produces bacteriocin are P. aeruginosa; pyocin, E. coli; colicin, Serratia 
Marcescens; marcescins, Enterobacter cloacae; cloacin, Bacillus megatarium; megacins 
and K. pneumoniae; klebicins.      
Bacteriocins kill the target cells by forming a pore on the surface of the cell envelope of 
the target cell or by penetrating the target cell and inhibiting the gene expression or the 
protein production (Mugochi et al, 2001; Cotter et al, 2013). The pore leads to the massive 
leakage of potassium ions from the sensitive cell that results in the death of the cell. 
Bacteriocin producing strains are protected from the effects of the bacteriocin by producing 
an inhibitor protein known as the immunity protein.      
Bacteriocins are very specific to the target (Zeth, 2012) and there are three steps of the 
killing mechanism;       
i)  Recognition of the toxin by the receptor present on the surface of the target cell.   ii) 
Movement of the toxin from the external surface to the inner side of the outer       
membrane, this is called translocation.    
iii) The toxin reaches its desired location and activates.      
Bacteriocins produced by Gram-positive bacteria are divided into Class I and Class II. In 
Class   I there are lantibiotics, thiopeptides, and in Class II there is mainly enterocin (Cotter 
et al, 2013). These bacteriocin are also useful as bio preservatives (Ghrairi et al, 2014). 
The bacteriocin produced by Gram negative bacteria are called microcins, they are narrow 
spectrum antimicrobial agents (Cotter et al, 2013). Some of these bacteriocin are strong 
antifungal agents and they are effective in controlling the spoilage in plants (Ghrairi et al, 
2014).      
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1.1.2.   Bacteriocin - Klebicin      
K. pneumoniae are gram negative bacilli, encapsulated and non-motile. It can be said that 
K. pneumoniae produce four types of klebicins as it has been reported in various research 
works; B, C, D and CCL. In a research study that was carried out in 2001 klebicin B gene 
was isolated from K. pneumoniae (Riley et al, 2001). The discovery of klebicin C and D 
gene clusters was brought forward in 2005 and in the same study they also reported the 
similarity of klebicin C and D gene with that of bacteriophage/bacteriocin (Chavan et al, 
2005) and the research article also refers to klebicin CCL by providing NCBI accession 
number AF190857. The molecular weight of klebicin varies from 5 kDa to 220 kDa, and 
this bacteriocin is hydrophobic with basic in nature.   
1.1.3.   The predicted structure of klebicin  
The structure of klebicin was predicted to be similar as colicin (Chavan et al, 2005). A 
generalised structure of a colicin comprises of three main parts; R domain; mediates 
attachment of the colicin with the target cell surface receptor, C domain; cytotoxic or the 
killer domain; enters the target cell and kills by various mechanism depending on the type 
of the colicin, and T domain; it is the translocation domain that locates the porin protein 
through which the C domain enters the target cell (Cascales et al, 2007).   
1.1.4.   The mode of action and the expression of bacteriocin genes  
The klebicins B, C and D are further classified based on their mode of action within the 
sensitive cell; C is a RNase colicin; kills the target cell by inhibiting the protein synthesis 
(hydrolyses the 16s rRNA), B is a DNase colicin (cleaves DNA), (Cascales et al, 2007) 
and D is a tRNase colicin (cleaves tRNA) (Cascales et al, 2007). The classification is also 
presented in figure 1.  
The expression of klebicin genes, their synthesis and release is by SOS response that is 
like the SOS response in E. coli. The key genes in klebicin C are kcp, kca and kci and in 
klebicin D are kdp, kda and kdi (Chavan et al, 2005). Genes kca and kda encodes for killing 
activity and genes kci and kdi encodes for immunity protein in klebicin C and D 
respectively. The kcp and kdp genes encode a protein that has 45% similarity to the phage 
tail like bacteriocin (Chavan et al, 2005). Klebicin B has the lysis gene as in most of the 
nuclease activity colicins but klebicins C and D does not have lysis gene in the operons 
and it was assumed that these would be the first nuclease activity bacteriocins that are 
closely related to colicins and they are without lysis genes (Chavan et al, 2005). In some 
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bacterial cells the producer cells only release bacteriocin if it is lysed, therefore expression 
of lysis genes leads to the lysis of the cell (Inglis et al, 2012). There is a clear need of 
further research to find out other types of klebicins that are hidden now, also there is a 50% 
possibility of discovering a phage tail like klebicin as suggested by Chavan et al, (2005).       
           
Figure 1: The colicins grouped in a phylogenetic tree showing clear similarity between bacteriocins; 
klebicins, colicins and pyocins. The similarities are based on homologous sequences. (Chavan et al, 2005).       
      
1.1.5.   Bacteriocin – Colicin      
Colicins are produced by E. coli. Colicins are classified into A, E1, E2, E3, E4, E5, E6, 
E7, E8, E9, K, L, M, N, Ia and Ib (Soelaiman et al, 2001, Cursino et al, 2002) and they 
compete with closely related strains during lack of space, nutrition or in response to the 
damages caused to the DNA of the bacteriocin producer cell by UV radiation or by 
chemicals like mitomycin C (Riley, 1993).   
The colicin gene is present in the plasmid also known as colicinogenic plasmid and they 
are of two types; small and large; small plasmids with size range of 6-10 kb cannot be 
transferred into another cell by conjugation because of less genetic material, large plasmids 
with size range of 40 kb are easily transferred by conjugation (Ghazaryan et al, 2014) and 
it is linked with two other genes; a gene that produces colicin toxin and a gene that protects 
the cell from the harmful effects of the toxin. In some E. coli cells, there are genes present 
for cell lysis. In these cells the colicin is released after the lysis of the host cell (Walker et 
al, 2004; Gordon et al, 2006). If the cell does not have lysis protein, then colicin is 
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transported in a vesicle to the cell membrane and released into the external environment. 
The release of colicin from the E. coli cells is mostly facilitated by the excretion through 
the cell membrane pores, only in few cases the cells went through autolysis, and it is 
possible that autolysis happens if the size of the colicin molecule is larger than the cell 
membrane pore size (Anthony et al, 1984).        
1.1.6.   Structure of colicin      
      
Colicins have three major structural aspects; R domain that is responsible for binding with 
the receptor present on the surface of the sensitive cell is in the centre of the primary 
sequence, T domain is the N terminal that is responsible for translocating the colicin from 
the receptor to the inside of the cell or the target site of the colicin and the last is the C 
domain that is responsible for the killing activity by either pore formation or nuclease 
activity. As an example, colicin E3 resembles a bow with two globular heads as T domain 
and C domain with the R domain in the middle like a string, figure. 2 (Soelaiman et al, 
2001). Between the C and T domains is the immunity protein that is responsible for 
protecting the cell from the lethal effects of its own colicin. In the second arm of the R 
domain every seventh residue is an alanine and therefore this region of the colicin E3 is 
called alacoil, it is thought that alacoil region makes helical flexible and antiparallel in 
such a way that two helical strands wrap around each other (Soelaiman et al, 2001).   
There are similarities between klebicins and colicins domains e.g., the translocation of 
domain of klebicin C is like the translocation domain of E1 colicin (Lazdunski et al, 1998), 
the receptor binding region of klebicin C is like the same region of klebicin D and the 
cytotoxic domain of klebicin C is like the corresponding region in colicins with RNA 
nuclease activity (Smarda et al, 1988).  
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Figure 2: Structure of Colicin E3 with all three domains; translocation in dark green, receptor binding in pale 
green, cytotoxic domain in blue and immunity protein in red. (Soelaiman et al, 2001).          
  
1.1.7.    Synthesis of Colicin      
      
Colicins are produced by the activation of SOS response which is a DNA repair system 
that is induced in response to the damage caused to the DNA. When a cell is in normal 
phase the SOS, response is turned off (Michel, 2005). The major role players in SOS 
response are two proteins; Lex A and Rec A. Lex A represses the expression of SOS genes 
by binding to the SOS box. If the DNA is damaged, then Rec A cleaves the Lex A and 
activates the SOS response and the colicin genes are synthesized. So, Rec A is also called 
an inducer or a regulator of SOS response (Michel, 2005).      
When a cell is exposed to UV irradiation, the level of LexA is decreased and simultaneously 
SOS genes are induced but only few SOS genes are activated initially and they are; uvrA, 
uvrB, uvrD, and an endonuclease UvrC (Michel, 2005). They catalyse the reaction that 
repairs the damaged DNA. This reaction is called nucleotide excision repair; the damaged 
nucleotide is excised from the DNA strand. At this stage the inducer recA is induced with 
a division inhibitor protein SfiA. This protein prevents the DNA from replication and give 
time to the cell to complete the repair process (Michel, 2005). If by this process the DNA 
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damage is not repaired then Pol V is induced, this is a polymerase that repairs the DNA 
but also introduces errors in base pairs.       
1.1.8.    Release of colicin from the host cell       
After synthesis, the colicin is released from the host cell and the mechanism of release of 
colicins varies; some colicins are secreted into the external environment whereas some 
colicins are released after the lysis of the cell. The mechanism of release is classified as 
selective and nonselective; the selective release is either leakage or lysis of colicins and 
non-selective release is the lysis of the cells but many researchers agree that colicins are 
released from the cell after the lysis of the host cell (Kim et al, 2014; Ghazaryan et al, 
2014).       
The lysis proteins play the most important role in the release of the colicin. The lysis 
proteins are small molecules with molecular weight around 4.5 kDa, with 20-41 amino 
acids (Howard et al, 1989; Cavard et al, 2004). They are synthesized in the cytoplasm and 
translocated into the inner wall of the outer membrane. Soon after the synthesis they are in 
precursor form and when they reach the outer wall of the inner membrane they are changed 
into the modified form, this process is known as acylation (Cascales et al, 2007).       
They facilitate the release of colicins by lysing the host cell (Cavard et al, 2004; Cascales 
et al, 2007) and they are also known as colicin release proteins. The accumulation of lysis 
protein inside the host cell induces following events; the alteration in the structure of the 
cell membrane; known as quasilysis, the activation of the outer membrane phospholipase 
A; this enzyme prevents the sudden breakdown of phospholipids present in the cell 
membrane and makes the cell membrane more permeable and the last event is the 
activation of autolysis; cell killing itself or cell death (Cascales et al, 2007). Unlike 
colicins, most of the lysis proteins have homologous sequence (Howard et al, 1989).      
1.1.9.    Colicin receptor and attachment      
After the colicin is released from the host cell it binds to the receptor present on the surface 
of the sensitive cell and that receptor assists the colicin molecule in entering the sensitive 
cell (Yamashita et al, 2008). In Table 1, the colicins are listed with their respective 
receptors. BtuB is a protein receptor to which colicins A and E1-E9 binds to before 
translocation (James et al, 2002). OmpF is an outer membrane porin protein that controls 
the permeability of the bacterial cell (Jaktaji et al, 2013). When the cell is in normal 
condition these porins are synthesized in large numbers but during stress e.g. in the 
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presence of antibiotics their synthesis is reduced to make cell impermeable (Jaktaji et al, 
2013).      
BtuB has 5 extracellular loops and they help colicin in attachment, once the colicin is 
attached through its receptor domain to the BtuB, the two arms of colicin T domain and C 
domain rest at 45°in such a way that they can locate a porin protein that can provide energy 
and space for translocation. This is achieved by the interaction between T domain and the 
Ompf porin (Bonsar et al, 2008). When colicin molecule is translocated into the cell it 
passes through two cytoplasmic membranes; outer and inner, depending on the killing 
activity of that colicin (Zakharov et al, 2012). The Ompf recruits Tol/Pal system for 
facilitating translocation of colicin, the Tol/Pal system has five proteins that form a link 
between outer membrane and inner membrane proteins and helps colicin in reaching the 
target in the cytoplasm Figure 3. The proteins are TolA, TolB, TolQ, TolR and Pal. These 
proteins are in different places between the inner and outer membrane (Walburger et al, 
2002). TolA, TolQ and TolR are inner membrane (IM) proteins, TolB is a periplasmic 
protein and Pal (Peptidoglycan associated lipoprotein) is an outer membrane (OM) 
lipoprotein (Gerding et al, 2007), Figure 3.   
  
Figure 3: Representation of Colicin attached to BtuB through the R domain while T and C domains rest at 
angle of 45°to the outer membrane OM and search for a porin protein OmpF. The porin protein provides 
energy and a channel to the colicin for translocating into the periplasm. The T domain initially interacts with 
two proteins of the Tol system; TolB and Pal, then TolA and R translocate the colicin into the cytoplasm 
(Bonsar et al, 2008).      
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Colicin  Receptor/Assisting protein  Translocation route  Mechanism of action  
A      BtuB/OmpF      TolA, B,Q,R      Pore formation  
B                        FepA               TonB, ExbB, D      Pore formation  
D                        FepA               TonB, ExbB, D                      Translation block  
E1  BtuB/TolC  TolA, B,Q,R  Pore formation  
E2  BtuB/OmpF  TolA, B,Q,R  DNA endonuclease  
E3  BtuB/OmpF  TolA, B,Q,R  rRNA endonuclease  
E4  BtuB/OmpF  TolA, B,Q,R  rRNA endonuclease  
E5  BtuB/OmpF  TolA, B,Q,R  Translation block  
E6  BtuB/OmpF  TolA, B,Q,R  rRNA endonuclease  
E7  BtuB/OmpF  TolA, B,Q,R  DNA endonuclease  
E8  BtuB/OmpF  TolA, B,Q,R  DNA endonuclease  
E9  BtuB/OmpF  TolA, B,Q,R  DNA endonuclease  
G  Fiu  TonB, ExbB, D  Membrane lysis  
H  Fiu  TonB, ExbB, D  Membrane lysis  
Ia  Cir  TonB, ExbB, D  Pore formation  
Ib  Cir  TonB, ExbB, D  Pore formation  
K  Tsx/OmpF, A  TolA, B,Q,R  Pore formation  
L  OmpA  TolA, Q, ND  Pore formation  
M  Fhua  TonB, ExbB, D  Inhibition of murein synthesis 
       N  OmpF/OmpC  TolA, Q,R  Pore formation  
Table 1: This table illustrates the types of colicins. The protein receptors provide attachment and support to the 
colicin, the translocation route is formed by a complex of proteins in the periplasmic space and that  assist 
colicins in passing through the cell membrane and inner membrane into the cytoplasm and the mechanism of 
action indicates the cytotoxic activity of colicin inside the sensitive cell. (Cursino et al., 2002).      
      
1.1.10.    Killing mechanism – pore formation or nuclease activity      
After entering the target cell, colicin either stays in the inner wall of the outer membrane 
for making a pore or channel that will lead to the loss of ions and the cell will lyse or the 
colicin will be translocated to the cytoplasm where the nucleases will degrade DNA or 
RNA and that will lead to cessation of transcription or protein synthesis and eventually the 
target cell will die. Inside the target cell, colicins execute anyone of the three major 
cytotoxic activities: i) pore formation; ii) enzymatic action that degrades the DNA and; iii) 
rRNA or tRNA (James et al, 2002). This theory is explained in more detail that all E 
colicins are divided into four classes based on their mechanism of action; the membrane 
depolarizing colicin is E1, colicins that degrade or digest DNA are E2, E7, E8 and E9, 
colicins that degrade rRNA are E3, E4 and E6, and colicin that degrade tRNA is E5 
(Kolade et al, 2002). All E colicins are plasmid encoded and these plasmids also codes for 
immunity proteins that are specific for each colicin to protect the host cell from the 
cytotoxic effects of their own colicin.      
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The colicins that form pores or ion channels in the inner membrane of the sensitive cells 
have molecular weight of 40-70 kDa (Lazdunski, 1995). Some factors are essential for a 
successful insertion of colicin’s C domain, those factors are; change in the length of helical 
arm of C domain, increased fluid content in the cell membrane that can make the layer 
more flexible, a balanced movement of positive charge across the bilayer of the sensitive 
cell and a thin cell membrane bilayer (Zakharov et al, 2004). On the other hand, are the 
nuclease colicins, they degrade DNA and RNA of the sensitive cell by entering the 
cytoplasm. They do not form voltage dependent channels instead the channel formed in 
this case only gives way to the colicin for reaching the cytoplasm and the time span of the 
channel is only milliseconds (James et al, 2002). The size and the sequence identification 
specificity is different in DNase and RNase domains; the DNase domain has 135 amino 
acids and the sequence specificity is 80% and RNase domain has 96 amino acids and the 
sequence specificity is 90% (Kolade et al, 2002).   
1.1.11.    Bacteriocins - Pyocin      
Pyocins are bacteriocins produced by the bacteria Pseudomonas species. There are three 
types of pyocins; R, F and S (Kuroda et al, 1979; Nakayama et al, 2000; Briand et al, 
2002). 90% of P. aeruginosa produces R and F types and 70% produces S type bacteriocins 
(Smith et al, 1992; Briand et al, 2002). The R and S type pyocins are further divided into 
R1, R2, R3, R4 and R5 and S1, S2, S3 and AP41 (Nakayama et al, 2000). The structures 
of R and F types are similar but R type has a non-flexible contractile tail and F type has 
flexible noncontractile tail figure 4. The F type pyocins are curved rods (Lee et al, 1998). 
The tail fibres of R-type pyocin TFi are made up of lipopolysaccharide and the TFi 
primarily facilitate the attachment of pyocin with the sensitive cell receptor figure 4.      
The structure of S-type pyocin is similar to that of colicin except that many S-type pyocins 
have three domains (El Farash et al, 2014); domain I is N-terminal that recognises the cell 
surface receptor, domain II has unknown function and domain III translocate and 
penetrates pyocin, C terminal domain carries out the killing activity (Michel-Briand et al, 
2002; Duport et al, 1995 ). S-type pyocin has two protein components; one is a larger than 
the other (Michel Briand et al, 2002). The larger component carries out the killing activity 
called effector component (Lee et al, 1998) and the smaller component is an immunity 
protein that is like the one in colicin, this protein protects the host cell from the killing 
activity of the larger component (Lee et al, 1998; Briand et al, 2002). The cytotoxic domain 
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of klebicin B is highly similar to the corresponding region in S-type pyocin (Chavan et al, 
2004).  
R-pyocin attaches to the surface of the cell then contracts the sheath. The contraction 
facilitates insertion of the core that passes through the cell membrane. The sensitive cell 
lyses due to the sudden shift in the charge of the cytoplasmic membrane (Uratani et al, 
1984; Kohler et al, 2010). The rate of killing of R-pyocins is high and they are specific in 
killing where one pyocin molecule efficiently kills one bacterial cell whereas about 100200 
F-type pyocin molecules are required to kill one bacterial cell (Briand et al, 2002; Kohler 
et al, 2010).        
      
Figure 4: Diagram of pyocins R and F. In R type the contractile sheath CS moves along the core C. The 
base plate BP settles on the surface of the target cell while the core works as injector. In F type, there 
is similar helical structure but without injector. The filament Fi facilitates the specificity for the 
attachment with the target cell’ surface receptor (Ishii et al, 1965; Furihata, 1972; Briand et al, 2002).        
The synthesis of pyocin involves genes recA, prtR and prtN and proteins RecA, PrtR and 
PrtN (Michel-Briand et al, 2002; Sun et al, 2014). The gene recA encodes a protein RecA 
that is responsible for the repair of damaged DNA, gene prtR encodes protein PrtR which 
is a repressor of gene expression and gene prtN encodes a protein PrtN which is an 
activator (Michel-Briand et al, 2002; Sun et al, 2014). During normal conditions or in the 
absence of a mutagen, the recA gene produces very small amounts of RecA protein (figure 
5). The gene prtR produces protein PrtR that binds to the promoter region of gene prtN 
and represses the synthesis of pyocin genes. But in the presence of a mutagen the recA 
produces protein RecA that cleaves the pyocin synthesis repressor protein PrtR thus giving 
permission to the transcription activator PrtN to activate the synthesis of pyocin genes 
(Briand et al, 2002; Sun et al, 2014). This mechanism is like the SOS response.      
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Figure 5: Induction of SOS response in Pseudomonas species- small amount of RecA protein is synthesized that does 
not cleave the repressor protein PrtR, and the expression of transcriptional activator gene prtN is repressed.  
II- in the presence of a mutagen, huge amount of RecA is synthesized that cleaves PrtR which is then not capable 
of binding to the promoter region of the gene prtN, thus PrtN is synthesized that activates the synthesis of pyocin 
genes (Ishii et al, 1965; Furihata, 1972; Briand et al, 2002).    
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VI.    AIMS and OBJECTIVES   
 
  
Klebsiella pneumoniae are in the genus Enterobacteriaceae. K. penumoniae causes infection in immuno 
compromised patients and therefore they are one of the major bacteria that causes hospital acquired 
infection.  
The aim of this project was to investigate K. pneumoniae for the synthesis of a novel bacteriocin. The 
bacteriocin that has been discovered previously in K. pneumoniae are klebicin B, C, and D. This 
research project had primarily focused on klebicins although other bacteriocins were discussed because 
klebicins are like other bacteriocins produced by various Enterobacteriaceae species.   
The aim of this research project was achieved by the following objectives:  
- reviewing the research articles focusing on klebicins   
- gaining a clear understanding of the different types of bacteriocins and their mechanism of 
action against the target cell   
- designing or selecting experiments that can isolate bacteriocin producer K. pneumoniae - the 
data that will be obtained will be compared to other projects.  
  
The isolation and identification of bacteriocin had several steps; from inducing the production of 
bacteriocin to isolation of bacteriocin by ion exchange and size exclusion chromatography. There were 
some experiments that were repeated throughout the project e.g., bioassay for detecting inhibitory 
activity of bacteriocin, SDS PAGE for confirming the lysis of the cells and release of proteins.  The 
major experiments were ion exchange chromatography; that isolated the protein of interest based on the 
net charge of the protein, and mass/spectrometry through which the protein of interest was matched to 
cloacin bacteriocin.   
The similarities between cloacin and the new bacteriocin give hints that both bacteriocin use the same 
receptor proteins, the same route of entry and have the same mechanism of action. The aim of the project 
was achieved and it leads to further research that can be done to study the specific characteristics of the 
new bacteriocin.  
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2. MATERIALS and METHODS  
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2.    Growth of K. pneumoniae 757 and 957      
Two strains of K. pneumoniae 757 and 957 were provided by the Public Health, UK, to 
the University of Lincoln, School of Life Sciences. The strains were grown in brain heart 
infusion broth and agar (BHI) (Fisher Scientific, UK) and incubated for 24 hours at 37°C. 
The strains were stored in BHI broth with 30 % glycerol at -80°C for unlimited amount of 
time.       
2.1.   Induction of bacteriocin production in K. pneumoniae 957      
In several previous researches Mitomycin C (ACROS Organics, UK) has been used for 
inducing the production of bacteriocin. Mitomycin C causes damage in the DNA and this 
triggers SOS response (Upreti et al, 1976; Chrisitne et al, 2004; Chun-Hoong et al, 2005). 
500mL of BHI broth was inoculated with 1-2 isolated colonies of K. pneumoniae 957, the 
broth was incubated for 24 hours at 37°C then 50µL of Mitomycin C, (the final 
concentration was 3µg/mL) was added into the overnight culture. The culture was again 
incubated for 24 hours at 37°C. The broth was centrifuged (Centrifuge 5430R Eppendorf) 
at 5725rcf for 20 minutes at 4°C. The pellet was retained and kept at -20°C for later use 
and supernatant was discarded. The pellet was stored at -20°C.      
2.1.1.   Lysis of K. pneumoniae 957      
The pellets were thawed at room temperature. Then to each pellet following items were 
added to facilitate maximum lysis of the cells; 1.5g <106µm glass beads (Sigma-Aldrich, 
UK), 1mL Protease K inhibitor (1 tablet was dissolved in 100 mL of sterile distilled water,   
Sigma-Aldrich, UK), 1mL DNase I (0.5 mL dissolved in 10mL of sterile distilled water, 
Thermo Fisher Scientific, UK), Tris base 1 mL (3.634g dissolved in 500 mL of sterile 
distilled water, the final concentration was 60.10 M, Fisher Bioreagents, UK), sterile 
distilled water 2mL and one magnetic flea, the final volume was 5 mL. The aliquot was 
vortexed at high speed for 15 minutes and centrifuged (Centrifuge 5430R Eppendorf) at 
5725rcf for 15 minutes at 4°C. The pellet contained glass beads, cellular debris and was 
discarded and the supernatant contained the proteins that were obtained from the lysed 
cells, therefore they were retained. The supernatant was centrifuged (Thermo Scientific 
Heraeus Fresco 17, Micro Centrifuge) at 17,000 x g at 4°C for 15 minutes. The supernatant 
was collected and sterilized by passing through 0.2 µm syringe filter. The filtered cell 
lysate was checked for inhibitory activity by setting up bioassay.       
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2.1.2.   Bioassay – a test for the inhibitory activity of K. pneumoniae 757  
In bioassay test, 10mL BHI broth was inoculated with K. pneumoniae 757. After overnight 
incubation 10 µL of broth culture of K. pneumoniae 757 was added to 1% soft agar (Agar 
Technical, Fisher Scientific,). The soft agar was poured over BHI agar. After the soft agar 
was set, 10 µL of cell lysate was spotted on the soft agar and allowed to dry. The plate was 
incubated overnight at 37°C and checked for clear zones indicating killing of K. 
pneumoniae 757 by 957.       
2.1.3.   SDS Poly Acrylamide Gel Electrophoresis      
12% polyacrylamide gels were used. The gel had 12 wells. Each well could accommodate 
maximum 20µL of the test sample. The gel was purchased from Bio Rad, UK. The SDS 
PAGE requires the use of running buffer, therefore SDS running buffer was prepared by 
using the recipe provided by Bio Rad. To 1L of distilled water following ingredients were 
added 30.3g of Tris base (0.20 M), 144g of glycine (1.95 M) (purity; 98.5%, Fisher Bio  
Reagents, UK) and 10g of Sodium Dodecyl Sulphate (0.034 M) (SDS, Fisher Chemical, 
Fisher Scientific, UK).       
In 20µL of cell lysate, 20µL of sample buffer was added (Sigma Aldrich, UK, buffer 
contained; 1 % SDS, 4 % 2-mercaptoethanol, 24 % glycerol, 0.02 % brilliant blue G, 0.1 
M Tris HCl, pH 6.8) this was heated at 95°C for 10 minutes. 20µLof the heated sample 
was loaded onto a 12% polyacrylamide gels (Bio Rad, UK). 5µL of protein ladder (Fisher 
Bioreagents, separates protein ranging from 10 kDa to 170 kDa) was loaded in the Lane 1. 
The samples were run on the gel with running buffer (SDS, etc.) at 30 mA for 60 minutes. 
The gel was stained in Quick Blue stain (Triple Red, UK). The bands on the gel were 
observed to determine the presence of proteins that confirmed the lyses of the cells. 
Polyacrylamide gels were also stained in silver stain (Invitrogen Silver Quest, UK). The 
reagents required for staining were provided by the manufacturer, they were diluted in 
distilled water. There were two staining methods; basic and fast. The difference was the 
time and the use of microwave. The basic silver staining method takes around 1 hour 30 
minutes and fast staining method involves use of microwave but the method takes only 55 
minutes (staining protocol can be found at 
https://tools.thermofisher.com/content/sfs/manuals/silverquest_man.pdf).      
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2.1.4.   Isolation of protein by overlay test      
At this stage, it was important to identify and isolate the protein of interest therefore, native 
PAGE was selected. The method was the same as SDS PAGE, but there are few 
differences; the buffer was free of SDS, buffer was kept in the refrigerator at 4°C until it 
was used, the samples were not heated at any stage and the electrophoresis gel tank was 
kept in a styrofoam box filled with ice. The aim was to prevent the denaturation of proteins 
either by chemical or by heat. The volume of the sample and the protein ladder was the 
same. At the end the gel was cut into half. One portion was stained and the other portion 
was left unstained because this portion was to be laid on the soft agar that was inoculated 
with K. pneumoniae 757, and the stain kills the bacteria.       
The unstained portion was overlaid on a BHI agar plate. The BHI agar plate was pre-
inoculated with K. pneumoniae 757. The gel lane was placed on the soft agar. The plate 
was incubated overnight at 37°C. The method was acquired from Grinter et al. The band 
on the gel will inhibit the growth of K. pneumoniae 757 in such a way that a line of 
inhibition will be formed that will be perpendicular to the gel strip (Grinter et al, 2012). 
That band will be considered as the bacteriocin protein band and will be excised and 
identified by mass spectrometry. A second overlay plate was set with a slight change; the 
gel was placed on the BHI agar and K. pneumoniae 757 was overlaid on the gel strip. The 
second experiment carried out for isolating the protein of interest was precipitation of 
proteins by ammonium sulphate.      
2.1.5.   Precipitation of protein by ammonium sulphate and salting out by dialysis      
Proteins in the cell lysate were precipitated by adding increasing concentrations of 
ammonium sulfate (Fisher Scientific, UK), the cell lysate was continuously stirred for 1 
hour on ice. 0.5mL of the sample was centrifuged at 17,000 x g for 15 minutes at 4°C. 
Supernatant and pellet were retained in separate tubes for bioassay, dialysis and PAGE. At 
the end of the experiment the total samples were 10 (table 2). Each sample had a pellet and 
a supernatant.       
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Initial Vol protein 
mL      
Final Vol protein   
mL      
Initial conc.      Final conc.     10% increase by 
weight g      
Vol centrifuged  
mL      
3.0  2.98     0%  50%  1.05  0.5  
2.98  2.58   50%  60%  0.19  0.5  
2.58  2.17   60%  70%  0.17  0.5  
2.17  1.74   70%  80%  0.14  0.5  
1.74  1.24    80%  90%  0.12  0.5  
Table. 2: The calculation table of ammonium sulphate used in precipitation of protein.       
The pellets were re suspended in Tris HCl buffer.  The supernatants and the re suspended 
pellets were dialysed to remove the ammonium sulfate. The dialysis tubing (Spectrum Lab, 
UK) with a pore size of 1 kDa was pre-wetted in Tris HCl buffer, all pellets and 
supernatants in dialysis tubing were immersed in 500 mL of Tris buffer (pH 7.6), for six 
hours in a shaking incubator, the samples were in constant movement therefor stirring was 
not necessary. Then buffer was replaced with a fresh stock, and dialysis was continued 
overnight. Bioassay plates were set up to check the presence of bacteriocin and SDS PAGE 
was performed to check if the proteins were successfully isolated from the solution.       
2.1.6.   Ion Exchange Chromatography      
The principal of ion exchange chromatography (IEX) is the separation of molecules based 
on the net charge present on the surface. Two buffers were used in this method; A and B. 
Buffer A was without salt and buffer B was with salt.   
The cell lysate was passed through anion column (GE Hi Trap 5mL, GE Healthcare, UK) 
for the separation by the charge present on the protein. The cell lysate was pumped into 
the column, the sample was mixed with buffer A (0.5M Tris HCl, filtered and degassed). 
Buffer B (0.5M Tris HCl, 0.5M NaCl) was pumped into the column at a gradient of 0 -  
0.5 M NaCl to elute proteins off the column. The volume for elution was set to 5ml/min. 
The eluent was collected in 1 mL aliquots and analysed by bioassay and SDS PAGE. The 
total number of fractions were 27.        
2.1.7.   Stability of bacteriocin at various temperatures      
The bacteriocin released by Gram-negative bacteria has shown stability at temperatures as 
high as 80°C for 30 minutes (Kayalvizhi et al, 2016; Kaewklom et al, 2013). This 
experiment was performed for a better isolation and identification of bacteriocin. Out of 
27 samples 5 samples were selected for SDS PAGE. Those 5 samples showed inhibitory 
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activity against K. pneumoniae 757 on bioassay plate. Eluted fractions obtained by anion 
exchange were selected from the results of the bioassay and SDS PAGE. To isolate and 
identify the bacteriocin further a heat stability test was carried out. The selected 5 samples 
were heated at temperatures 40, 45, 50, 55, 60, 65, 70, 75, 80°C for 15 minutes. The 
samples were centrifuged for 15 minutes at 4°C and 17000 x g. 40µL of supernatant was 
analysed by SDS PAGE and bioassay test. 20µl of cell lysate was used in each test.   
2.1.8.   Size exclusion chromatography      
The column used was Superdex 200, 10/300 GL, and there were two samples for 
purification. Total volume of each cell lysate was 0.7mL. Elution volume was set at 
1mL/min. In size exclusion chromatography, the molecules are separated based on their 
sizes, the smallest molecules are eluted in the end and the biggest are eluted in the 
beginning. There is only one buffer used that is called HEPES buffer (10 mL of 1 M Hepes 
buffer and 10 mL of 5 M NaCl dissolved in 500 mL of distilled water, Fisher Scientific, 
UK).       
The valves are always left in the 20 % ethanol to avoid contamination, but before purifying 
the protein samples it is important to wash the valves, otherwise ethanol will precipitate 
the protein and it will cause blockage in the valves. Total fractions (each fraction was 1 
mL) obtained from this chromatography were 32 each for both samples. The samples were 
checked for inhibitory activity on bioassay plates, and confirmed for the presence of 
protein by SDS PAGE. This technique confirmed the presence of bacteriocin in the sample 
and number of positive fractions were narrowed. The result indicated that bacteriocin 
present in the cell lysate are similar in size to the bacteriocin identified by MASS 
Spectrometry.       
2.1.9.   Mass/Spectrometry      
Mass/spectrometry is a technique that identifies molecules based on their charge to the 
mass ratio. Every mass/spectrometer has three major sections; ion source, analyser of 
mass, and ion detector and a computer attached to it for controlling the process and 
obtaining the data. The sample can be liquid, gas or even solid. Before reaching the ion 
source the sample is changed into vapours, and these vapours are ionized upon entering 
the ion source 
(https://www.thermofisher.com/uk/en/home/lifescience/proteinbiology/proteinbiologylea
rning-center/protein-biology-resource-
library/pierceproteinmethods/overviewmassspectrometry.html#Thermo Fisher, UK).  
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In the ion source the molecules receive charge and then they are passed into mass analyser, 
which has a magnetic field. In mass analyser that charged molecules are deflected towards 
the ion detector, those molecules that hit the ion detector are identified by a computer that 
has the software for identification of the molecule. 
  
  
  Figure 6: An illustration of Mass/Spectrometry. The sample molecules are vaporised; the filament heats up and       
produces beam of electron that hits the sample molecules and changes them into ions and the molecules then 
brakes into fragments. The fragments carry the same charge but their masses are different. The fragments pass 
between the magnets and the fragment that hits the detector is identified. 
(http://www.foothill.edu/psme/armstrong/MS.shtml)  
2.1.10   Summary of the method  
This is a flow diagram on page 27 that shows all the steps and experiments of this project in a 
concise manner.  
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SUMMARY OF THE METHOD  
    
    
Figure 6: A flow chart illustrating the summary of the method.        
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3.   The confirmation of production of bacteriocin by the K. pneumoniae      
      
The first step in this project was to confirm the production of bacteriocin by K. 
pneumoniae. Bioassay tests were carried out for examining the production of bacteriocin 
by K. pneumoniae 957 (bacteriocin producer strain) and the inhibition of growth of K. 
pneumoniae 757 (strain sensitive to bacteriocin). The strains of K. pneumoniae were grown 
in Brain Heart Infusion (BHI) broth. The positive result was indicated by the zones of 
inhibition formed by K. pneumoniae 957 against K. pneumoniae 757.      
In the next step K. pneumoniae cells were lysed and the cell lysate was checked for the 
presence bacteriocin by bioassay test. In Figure 1A, the cells K. pneumoniae 957 were 
intact therefore the zone of inhibition was a white creamy growth of K. pneumoniae 957 
surrounded by translucent growth of K. pneumoniae 757. In Figure 1B the cell lysate of K. 
pneumoniae created a zone of inhibition in a circular area without any growth and 
surrounded by a lawn of   
growth of K. pneumoniae 757. The first experiment concluded that K. pneumoniae 957 
cells were producing bacteriocin that was released in the external environment.                                                 
  
1A                                                                             1B  
          
Figure 1: 1A and 1B: The agar plate used above was Brain Heart Infusion (BHI). In 1A the BHI agar was 
overlaid with sensitive strain K. pneumoniae 757 and bacteriocin producer strain K. pneumoniae 957 was 
spotted on (circled in black). The volume of each spot was approx. 10µl and the volume of sensitive strain 
was 10µl inoculated in 10mL of agar technical (soft agar), K. pneumoniae 957 inhibited the growth of K. 
pneumoniae 757 and formed clear zones. In 1B the clear zones were formed by cell lysate obtained after the 
lysis of the bacteriocin producer strain K. pneumoniae 957.    
      
3.1.   Confirmation of cell lysis      
Bioassay was followed by SDS Poly Acrylamide Gel Electrophoresis (PAGE) for the 
confirmation of the lysis of bacterial cells and release of proteins (figure 2). In SDS PAGE 
the separation of proteins is based on the net charge present on the macro molecule. SDS 
is a detergent that when binds to the macro molecule breaks the structure of the protein 
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and changes it from coiled form to linear form. SDS carries a negative charge therefore 
the macro molecule acquires the same charge and moves towards the positive pole or 
anode.       
The polyacrylamide gels were stained with Coomassie blue stain. The protein ladder used 
had molecular weight markers ranging from 170 kDa to 11 kDa. The presence of protein 
bands in lane 1 (figure 2) indicated that the cells have been lysed to release the contents of 
the cytoplasm and the lysis method was good but this was qualitative analysis only. A 
quantitative test could have been performed to analyse the concentration of protein in the 
cell lysate that could have helped in analysing the efficiency of the method used for lysing 
the cell.  
  
Figure 2: SDS PAGE. 12% Polyacrylamide gel with cell lysate from K. pneumoniae 957 in lane 1. Gel was 
stained with coomassie stain. The volume of protein ladder was 5µL and the volume of samples was 20µL 
in each well. Sample was running on the gel for 60 minutes at 30mA and 200volts. The presence of bands 
on the gel confirmed the lysis of K. pneumoniae 957.   
  
3.1.1.     Identification and isolation of bacteriocin by overlay plate method      
In the first step, it was confirmed that bacteriocins were present in the cell lysate. The next 
step was to identify a band present on the polyacrylamide gel as a bacteriocin band because 
there were many protein bands. The test that was carried out for achieving this aim is called 
gel overlay test. The expected result was the formation of a line on the agar, adjacent to 
the protein band present on the gel strip. The line would correspond with the bacteriocin 
present on the gel and the line would indicate the inhibition of growth K. pneumoniae 757 
by K. pneumoniae 957. This way the bacteriocin band can be isolated and identified.       
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Figure 3: Native PAGE. The sample was running on the 12% polyacrylamide gel under the same conditions 
as SDS PAGE (Figure 2). In native PAGE the protein is not denatured from coiled form into linear form 
therefore the protein bands are mostly condensed in the upper portion of the gel.        
      
To obtain the gel with active protein it was necessary not to denature the proteins therefore 
the method of choice was native PAGE. The samples were run in duplicates; half portion 
of the gel was stained and the other half was left unstained for the overlay test. The 
unstained portion was excised and placed on the soft agar. The result was not as expected. 
The inhibition of the growth of K. pneumoniae 757 did not corresponded with any of the 
bands on the gel. The growth was inhibited only underneath the gel strip (figure 4). The 
second method of overlay test was also performed but the result was the same as the first 
overlay method.  The proteins could not be isolated by the overlay method therefore the 
cell lysate was precipitated by adding ammonium sulphate and the salt was removed by 
overnight dialysis.                                                   
 
was pre-inoculated with K. pneumoniae 757). After overnight incubation the lawn of growth was completely 
inhibited underneath the gel strip, but there was no formation of line of inhibition corresponding with the band 
present on the gel.       
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3.1.2.   Isolation of target proteins using ammonium sulphate and dialysis  
To isolate the proteins increasing concentrations of ammonium sulphate was added into 
the cell lysate. The cell lysate was centrifuged and the supernatant and pellet were dialyzed 
overnight against the Tris buffer.       
The supernatant and the pellet obtained after precipitation were dialyzed overnight in 500 
mL of 30 mM Tris base, the samples were plated on BHI agar for bio assay test and were 
checked for purification on SDS gel and native gel (figure 6).       
The bioassay test came negative for all the samples; there was no clear zone was present 
in any sample and the SDS gel did not show protein bands. It was possible that protein was 
too diluted and could not be stained by coomassie blue or the destaining time was not 
sufficient. The presence of clear zone on BHI plates before ammonium sulphate 
precipitation test confirmed that samples had bacteriocin and therefore the absence of clear 
zones in the samples after dialysis indicated loss of protein from the sample (figure 5). The 
samples were checked for inhibitory activity before starting the precipitation technique but 
they were not checked after the technique was over. The loss of protein can also happen 
due to the concentration of ammonium sulphate, if the concertation of salt was low and 
water was not completely removed then protein can easily be degraded and will not be able 
to perform normal function but they might be still visible on the gels.       
   
BHI agar plate was overlaid with K. pneumoniae 757 
pre-inoculated soft agar. On the soft agar, dialysed 
cell    
lysed was spotted on (circled). None of the circles has 
zone clearing.  
  
  
  
  
  
Figure.5: Bioassay tests. Bacteriocin sample was precipitated by ammonium sulphate. Dialysed against 
30mM Tris HCl and checked for inhibitory activity against K. pneumoniae 757. All the samples were 
negative, there was no zone clearing.  
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Figure 6: Native PAGE with dialysed cell lysate. Each sample was treated with ammonium sulphate. S1;  
0.89g, S2; 0.15g, S3; 0.13g, S4; 0.10g, S5; 0.07g      
      
3.1.3.    Ion Exchange Chromatography (IEX)      
Ion Exchange chromatography is a technique that purifies protein based on the net charge 
present on the surface of the molecule.       
In ion exchange chromatography, the column size was 5 mL and it was an anion column, 
(the charge of the resin is positive and protein that attaches to it is negatively charged). In 
the experiment two types of buffers were used; loading buffer and the elution buffer. Both 
buffers were Tris base with pH 7.6. Elution buffer had 0.5 M NaCl as salt gradient because 
salt removes the proteins that are attached to the column. The pI of the protein of interest 
was unknown. The total number of fractions obtained after purification was 1-27. All the 
fractions were checked by SDS PAGE for separation (Figure 8) and on bioassay plates for 
the inhibition activity (Figure 6). Although the pI of the protein is unknown but from figure  
7, it seems that pI of the protein (bacteriocin) in the first peak is greater than the pH of the 
buffer that is 7.6. The proteins (bacteriocin) that were eluted were positively charged and 
those retained and eluted at a later stage were more negatively charged and the pI of the 
proteins that were retained and eluted at higher salt concentrations was higher than the pH 
of the buffer.  
The higher the concentration of the bacteriocin in a sample will be, the clearer the zone of 
inhibition will be. Fractions 1-17 were positive and fractions 0-1 and 18 to 26 were 
negative. Fraction 27 was crude preparation or the starting material that was passed into 
the column. It was expected to obtain a positive result only between fractions 7-18 but 
most of the fractions were positive. There was a possibility that salt in the buffer was the 
reason for the zone clearing. Therefore, the buffer only sample was eluted and plated for 
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bioassay test, in the absence of bacteriocins. All buffer only fractions were negative and it 
was confirmed that salt in the buffer was not killing K. pneumoniae 757.      
   
Figure 7: mAu; mass absorbance unit. Graph indicating the purification and elution of bacteriocin sample of 
K. pneumoniae. Total number of fractions was 25 (red). Samples 1 – 5 were flow through, sample 6 was a 
blank and samples 7 – 25 were elution of bacteriocin. The first two peaks of fractions 1-5 indicates that in 
an anion exchanger column, the samples eluted first were proteins with only few charged groups and were 
eluted in low concentration of salt. The middle peak represents those proteins that had many negatively 
charged groups therefore salt had to compete with these proteins for the space on the resin. Therefore, these 
proteins were eluted when high concentration of salt was applied. The last peak had no proteins in the 
fractions that was confirmed by bioassay test plates, all the samples 18-25 were negative with no zones of 
inhibition.      
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Figures 8; a, b, c, and d: fractions obtained from IEX chromatography were checked for proteins by 
SDS PAGE. Sample 27 is the starting material. In figure 8 a, there was no sample 6 because after 
fraction 5 there was a blank tube, then automated volume started to elute from fraction 7.      
  
The fractions obtained from Ion Exchange chromatography were tested for inhibitory 
activity on bioassay test plate, samples 1 – 17 were positive with clear zones of inhibition, 
this confirmed that in elution bacteriocin was present. The number of positive fractions 
obtained were more than expected therefore all fractions were selected for heat stability 
experiment.       
3.1.4.   Effect of temperature       
With the help of IEX chromatography it was possible to select the purified protein samples 
that produced clear zones on bioassay plates. But the number of fractions obtained were 
more than expected so it became necessary to carry out another experiment that will help 
in isolating the protein of interest. To purify and isolate proteins further, the fractions from 
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IEX chromatography were subjected to various temperatures. Researchers that have 
worked with bacteriocin in the past have observed that klebicin and colicin can stay active 
at temperatures around 70° -75°C. They degrade at or above 80°C. In this research study 
the temperature range was from 40°C – 80°C, with 5°C increase each time and 15 minutes 
of heating period in a water bath. In the first round all fractions were positive for 
bacteriocin up to 70°C, and for the second round from these fractions 4, 11, 15 and A (the 
starting material) were selected for the heat stability test. The temperature range was same 
as the previous experiment. In the second test the fractions showed activity on the plate up 
to 70°C (figure 9) but the protein bands on the SDS gel disappeared after 60°C (figure 10). 
This indicated that bacteriocin lost their surface charge after 60°C and could not be traced 
on the SDS gel but can show inhibitory activity on the agar plates up to 75°C although it 
can be seen from figure 9E, the clear zones at 75°C were very weak but still visible under 
black background.   
  
 
Figure 9: Top left to right: A 40°C, B 50°C, C 60°C, from bottom left to right: D 70°C, E 80°C. Fraction No. 
4 of Ion Exchange chromatography was checked for inhibitory activity by carrying out bioassay test. The clear 
zones are indicated by circles. The fraction that was heated to 80°C does not have clear zones.     
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The results were the same for fractions 11 and 15. Therefore for the final heat stability test 
only fractions 4 and 11 were selected and temperature ranges were 50°, 55° and 60°C. 
Fractions were incubated at each temperature for 15 minutes, then centrifuged and 30µL 
was pipetted out, 20µL for SDS PAGE and 10µL for bioassay test.       
The bioassay result showed inhibitory activity on BHI agar on all three temperature ranges.  
In the SDS PAGE the protein bands were clearly visible at 60°C that can be seen in figure  
11.      
     
Figure 11: Fractions 4 and 11 on SDS poly acrylamide gel. The fractions were heated at three temperature 
ranges only, 50°, 55° and 60°C. Fraction 4 was eluted in the beginning of Ion Exchange chromatography as 
illustrated in figure 7 and the concentration of the protein was less in this elution, therefore the protein bands 
appear weak in all SDS gels that contained fraction 4.       
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Figure 12: 12A and 12B: Samples 11 and 4 were also stained in silver stain because coomassie blue stain does 
not highlight weak protein bands whereas silver stain is highly specific for protein because it can stain as minimum 
as 1µg of protein. Samples were heated as 55°, 60° and 65°C with 15 minutes of incubation time at each 
temperature.       
Both samples were stained in silver stain. The bands in Sample 4 were very weak, it might 
be due to repeated freeze and thawing or the sample was too diluted when it was loaded in 
AKTA Prime for ion exchange. Both sample showed good inhibitory activity on BHI agar 
plate.       
      
3.1.5.    Size exclusion chromatography      
  
Two samples were selected from the heat tolerance test of bacteriocin. Samples 4 and 11 
were showing very clear bands at the temperature range of 60°C and the molecular weight 
range. The prime interest in performing the size exclusion was to narrow down the large 
number of bacteriocin positive samples that were obtained by ion exchange 
chromatography that separated the proteins based on their net charge and it was obvious 
from the results that protein of interest carries positive charge. In the size exclusion 
chromatography elution of sample 4 there were only 9 positive samples with inhibitory 
activity and the presence of protein in the sample on the chromatogram corresponded 
accurately with the band selected from the SDS gel at 72 kDa. In sample 11 the 
chromatogram showed more than one peak and the presence of bacteriocin was confirmed 
by performing bioassay of the fractions under the peak of interest, therefore in sample 11 
the presence of bacteriocin was suspected in two samples and they both were sent for the 
identification of protein by MASS/Spectrometry.       
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3.1.6.   Bioinformatics – identification of a possible match of the target protein      
      
The protein bands from both fractions at 60°C were selected for tandem 
MASS/SPECTROMETRY. Bands A and B from fraction 4 and band C from fraction 11 
were excised and sent for tandem MASS/SPECTROMETRY (figure 11). The bands were 
matched with the following: band A; cloacin, band B; heat shock protein and band C; 
superoxide dismutase. The cloacin is a bacteriocin produced by Enterobacter cloacea. 
Superoxide dismutase is synthesized by the sensitive cell when the cell goes under stress 
of any kind (Christopher et al., 1987). The third band was found like a heat shock protein 
Hsp20, this molecule has the molecular weight lower than 20kDa and by looking at Fig. 
11, of SDS gel the band in sample 11 was at 17 kDa. It was obvious that bacteriocin sample 
was subjected to temperatures 45° – 80°C but there were no intact cells to release the heat 
shock protein. Therefore, the only possibility is the release of this protein during the lysis 
process. Cells were vortexed on highest speed for 15 minutes; this could have triggered 
the release of Hsp20. The      
BLAST search was used for finding the homologous sequence. There could have been any 
one of the three implications; if there will be an exact match of the sequence obtained from 
MASS /SPECTROMETRY then it will indicate that the target bacteriocin was found 
previously, if there will be no match in the database for klebicin then it is likely that there 
is another bacteriocin produced by K. pneumoniae or a new type of klebicin has been found 
in this research project.       
After the BLAST search the closest possible match was found to be cloacin ribonuclease 
bacteriocin and the second possible match was colicin E6 that is also a ribonuclease. The 
homology between the sequences was found as a whole sequence and with each of 
domains; translocation, receptor and cytotoxic. This result has been further discussed in 
chapter no. 4.         
     1  MAFGLPALAT  PGAEGLALSV  SGDALSAAVA  DVLAALKGPF  KFGLWGIAIY 
    51  GVLPSEIAKD  DPKMMSKIVT  SLPADTVTET  PVSSLPLDQA  TVSVTKRVAD 
   101  IVKDERQHIA  VVTGRPMSVP  VVDAKPTKRP  GVFSVSIPGL  PSLQVSVPKG 
   151  VPAAKAPPKG  IIAEKGDSRP  AGFTAGGNSR  EAVIRFPKES  GQKPVYVSVT 
   201  DVLTPAQVKQ  RLEEEKRRQQ  AWDAAHPEEG  LKREYDKAKA  ELDAEDKNIA 
   251  TLNSRIASTE  KAIPGARAAV  QEADKKVKEA  EANKDDFVTY  NPPHEYGSGW 
   301  QDQVRYLDKD  IQNQNEKLKA  AQTSLNEMNE  SLSRDKAALS  GAMESRKQKE 
   351  KKAKDAENKL  NEEKKKPRKG  TKDYGHDYFP  DPKTEDIKGL  GELKEGKPKT  
   401  PKQGGGGKRA  RWYGDKKRKI  YEWDSQHGEL  EGYRASDGEH  LGAFDPKTGK  
   451  QVKGPDPKRN  IKKYL 
Figure 13: Sequence provided by mass/spectrometry. The region highlighted in red letters are the peptide 
sequence found by mass/spectrometry.   
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The figure 13 shows the sequence in red and black. The bold red segments of the peptide 
sequence were found by mass/spectrometry that was best matched with the peptide sequence in 
black, and that relates to the cloacin bacteriocin.          
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4.   Bacteriocin production       
There were two strains of K. pneumoniae 757 and 957. The strain K. pneumoniae 757 was 
sensitive to bacteriocin and the strain K. pneumoniae 957 was a bacteriocin producer. The 
aim of this research was to identify and isolate the bacteriocin produced by K. pneumoniae. 
The K. pneumoniae bacteriocins that have been found and researched previously are 
klebicins A, B, C and D (Buffenmyer et al, 1976). Other Gram-negative Enterobacteriacea 
produces many different types of bacteriocins therefore it can be easily assumed that K. 
pneumoniae might also be producing many different types of bacteriocins that are still to 
be discovered.      
K. pneumoniae produces bacteriocins in standard conditions e.g., when competing for 
space or nutrition with the closely related species, but when the DNA is damaged the 
production of bacteriocin increases with the activation of SOS response.      
The research project started with the confirmation of the release of bacteriocin by K. 
pneumoniae 757. In this confirmatory test the production and the release of bacteriocin 
was natural and without the use of an inducer. Therefore, it can be said that release of 
bacteriocin was for competing for the space and the nutrition against K. pneumoniae 757 
strain.       
The strain K. pneumoniae 957 was grown in BHI broth in the presence of mitomycin C for 
increased production of bacteriocin and cell lysate was obtained and confirmed for 
inhibitory activity. The lysis of the bacterial cells was confirmed by SDS PAGE. This step 
was important because intact cells also release bacteriocin and forms clear zone of 
inhibition, and the similar result is observed by using cell lysate but SDS PAGE shows 
protein bands on the poly acrylamide gel and that confirms the lysis of the cells and release 
of the proteins.      
4.1.   Native PAGE for agar overlay test – isolation of protein band      
To be able to observe the inhibitory activity of bacteriocin on the agar plate the native 
PAGE was carried out. The expected result was the formation of inhibition line on the agar 
that would correspond with the protein band on the gel. This inhibition line is formed by 
the inhibition of the growth of sensitive bacteria by the bacteriocin present on the gel, but 
the inhibition of sensitive bacteria happened underneath the gel that acquired the shape of 
the gel. The target protein band could not be isolated by the overlay method. After several 
repeats few possible issues were considered that might have caused this; the gel layer might 
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have created anaerobic environment, a much diluted bacteriocin could have diffused all 
over the gel or the poly acrylamide present in the gel could have done the killing. The test 
was performed with unused poly acrylamide gel strip and there was no killing of sensitive 
cells underneath the gel strip which concluded that the environment was not anaerobic 
under the gel strip and the poly acrylamide did not kill the sensitive bacterial cells.       
4.1.1.   Precipitation of protein       
So, by overlay plate the target protein could not be isolated, therefore for isolating the 
protein the ammonium sulphate method and dialysis were carried out. This method was 
adopted from a research work carried out by Grinter et al, (2012), they found structural 
similarities between syringacin M and colicin M, and the similarity was between the 
receptor binding domains of both the proteins. They used the overlay native gel technique 
to isolate the protein band of the interest on the native gel strip that was overlaid on a base 
agar.       
The result obtained in the research work by Grinter et al, (2012) was not in agreement with 
our research work due to negative result or the absence of line of inhibition therefore the 
purification of protein was performed by using ammonium sulphate. The bioassay result 
was negative for all the samples after the dialysis but these samples were checked for 
inhibitory activity before the precipitation and they were positive with zone clearing, 
therefore it cannot be assumed that cells did not lyse and proteins were not present in the 
cell lysate before performing the purification techniques. This purification method has 
been used for purifying bacteriocin by many researchers. A bacteriocin syringacin M 
produced by Pseudomonas syringae was successfully purified by this method (Grinter et 
al, 2012) and in another study thermophilin T a bacteriocin produced by Streptococcus 
thermophilus was purified. In contrast to both research studies, the only possible factor 
that might have caused the loss of protein is the concentration of ammonium sulphate and 
the percent increase value.       
According to Wingfield (2001), the protein with lower molecular weight (<30.93 kDa) 
should be precipitated with higher concentrations of ammonium sulphate, and protein with 
higher molecular weight can be precipitated with less than 20% saturated ammonium 
sulphate. At this stage the molecular weight of the protein was not known but after the ion 
exchange chromatography the molecular weight was found to be around 70 kDa. It is 
possible that proteins were lost during the precipitation process due to less concentration 
of salt. The samples were not checked for inhibitory activity after the precipitates were 
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collected therefore it can only be assumed that loss of protein occurred during this process. 
The dialysis bag had the MWCO of 1 kDa, this means any protein larger than 1 kDa will 
stay inside the dialysis bag therefore it cannot be assumed that protein leaked out of 
dialysis bag because of the larger pore size of the dialysis bag. Therefore, if this technique 
is repeated for the same research project then two changes should be applied; higher 
concentration of saturated ammonium sulphate and for a better precipitation of protein at 
4°C, the salt can be diluted in distilled water.       
4.1.2.   Purification by ion exchange chromatography      
The proteins could not be separated by the above technique therefore ion exchange 
chromatography was selected. The protein of interest was eluted in the initial samples 
whereas it was expected that protein will be eluted toward the middle of the elution 
process. An anion column is positively charged and it holds negatively charged proteins 
very firmly.       
The reason that protein was eluted in flow through samples could be that bacteriocin carries 
positive charge and so it did not stick to the column. If the same sample was running 
against a cation column that is negatively charged, the proteins would have eluted towards 
the middle because the column would hold oppositely charged proteins very firmly, and 
they would elute only after higher concentration of salt that would have taken the space on 
the cation column and bacteriocin molecules would have been forced to leave the column 
by salt molecules. The result was in complete agreement with the bioassay result based on 
the presence of inhibitory activity on BHI agar plate. But the number of positive results 
were more than expected, the SDS gel showed numerous intense bands with wide range 
of molecular weights.       
As mentioned in introduction chapter that klebicins are hydrophobic (Al-Jumaily et al, 
2012) a hydrophobic column can also be a good choice for purifying proteins. The obvious 
factor that might have caused early elution of protein in the experiment is the use of anion 
column that lead to the elution of samples in the flow through because proteins did not 
stick to the column due to repulsive or similar charges, it can be said here with assurance 
that that result will be different with a cation or hydrophobic column.       
Since the number of positive samples with zone clearing were 25, it was very important to 
perform further experiment that will select the protein of interest because the aim of the 
project was to isolate and identify the bacteriocin. Therefore, eluted fractions from IEX 
chromatography were subjected to various temperatures. In previous research, it was found 
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that klebicins do stay stable above 100°C for 30 minutes but after 70°C they do not show 
inhibitory activity against the sensitive strain (Al-Jumaily et al, 2012) and a research work 
performed previously showed the bacteriocins released by Gram-negative bacteria stay 
stable at temperatures close to 70°C but above this range they do not show killing activity 
(Kayalvizhi et al, 2016; Kaewklom et al, 2013). Therefore, this method was found relevant 
for isolating the protein of interest or bacteriocin from a batch of 25 fractions. The result 
of this experiment was in complete agreement with the research performed by Al- 
Jumaily et al, (2012) and Ghazaryan et al, (2014), they found that between the temperatures of 
30°C – 45°C the inhibitory activity of bacteriocin was maximum and the activity became less and 
weak around 65°C.       
4.1.3.   Size exclusion chromatography      
The two samples were selected for size exclusion chromatography because this technique 
separates the protein based on the size and it was expected that protein of interest will be 
easily highlighted because now at this stage there was ion exchange fraction, SDS gel 
results, and bioassay results. A band that was visible on SDS gel at a specific molecular 
weight at or above 65°C, the same fraction also showed inhibitory activity on the bioassay 
plate. The same fractions were purified by the size exclusion chromatography, and were 
checked for inhibitory activity on bioassay plates alongside the separation on SDS gel. The 
bands that were present at the same molecular weight in ion exchange chromatography, in 
size exclusion chromatography and showed the inhibitory activity on BHI agar plates were 
selected as proteins of interest and those bands were identified by MASS/Spectrometry. 
All three bands represented the fractions that were heated at 60°C for 15 minutes.        
4.1.4.   Mass/Spectrometry      
There were three possible matches found by MASS/Spectrometry; cloacin for the band at 72 kDa, 
superoxide dismutase at 26 kDa and heat shock protein Hsp20 at 17 kDa. Although this result was 
more helpful and directed towards the target protein as compared to size exclusion 
chromatography. The presence of superoxide dismutase was not a surprise, because this an 
enzyme that is produced by the cell during heat shock, vigorous vortexing or growing cells in a 
shaking incubator. The shock can be internal or external and can be due to physical or chemical 
factor. It is evident from the previous research that E. coli produces superoxide dismutase 
during the stress period (Privalle et al, 1987; Gregory et al, 1973).        
Although the interesting fact is that cells were lysed in the beginning of the experiment, 
the process of lysing the cells did not involve heat shock at all, instead the cells were 
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vortexed intensely with glass beads and magnetic stirrer. This result lead to two answers, 
either the K. pneumoniae produced superoxide dismutase due to vigorous vortexing or 
there is protein in the band that was almost the similar in sequence to that of superoxide 
dismutase. The confirmed answer can only be obtained by running sample 4 in a size 
exclusion column and then checking the inhibitory activity on bioassay plate. Since the 
band size 26 kDa will elute after the first band at 72 kDa. If the fraction showed inhibitory 
activity, then it is a bacteriocin with a similar sequence and the molecular weight or if there 
is no inhibition on the bioassay plate then it is superoxide dismutase produced by K. 
pneumoniae at the time of lysis.       
4.1.5.   BLAST search for homologous peptide sequence      
The possible match at band 17 kDa in sample 11 was heat shock protein with a molecular 
weight of 20 kDa. Heat shock proteins are found in eukarya, bacteria and archaea. By the 
name it seems that the protein is only produced when the bacterial cell is subjected to 
higher temperatures. Li et al, (2011) stated in their article that small Hsp are produced 
under physical, chemical stress and some cells constantly produce Hsp, their size range is 
12-43 kDa. Their function is to prevent unfolded protein molecules from degradation. The 
same conclusion can be drawn about Hsp20 that during the lysis process cells were not 
subjected to heat, but there was vigorous vortexing that could lead to production of Hsp20 
or may be the cell was producing it irrespective of the type of stress. Since the size of 
klebicin ranges from 5-220 kDa (Al-Jumaily et al., 2012) again it is important to purify 
the fraction of sample 11 by size exclusion chromatography to differentiate between a 
possibility of the Hsp20 or a novel bacteriocin have a similar molecular weight. The 
fraction should be checked for inhibitory activity on bioassay plate.       
The band 72 kDa was found to be like cloacin. There is a similarity in the protein sequence which 
determines that a possible target protein has a great similarity in the protein sequence with that of 
cloacin. The klebicins that have been discovered already are A, B, C and D. The molecular weight 
of these klebicins are 79 kDa, 66 kDa, and 76 kDa, the mass of klebicin A is unknown. The mass 
of protein discovered in previous studies were like the mass of suspected protein that is 72 kDa. 
There is a high possibility that band at 72 kDa is a new klebicin, it can only be confirmed by 
comparing the sequences of klebicins A, B, C and D available in the data bank.       
If there is a 100% similar homologous sequence, then the protein found in the research work is not 
novel and if there is not 100% similar sequence then it will indicate that the protein at 72 kDa is a 
new protein found in cell lysate of K. pneumoniae. The sequence that was matched at band A was 
used for searching a homologous sequence through BLAST search. The Blast search gave the 
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highest possible match to cloacin ribonuclease for all three domains; translocation, receptor and 
cytotoxic domains.     
4.1.6.   The new bacteriocin       
      
Through the BLAST software the sequence was search for homology; all domains and individual 
domains. The sequence in question was closely matched with the sequence of cloacin ribonuclease, 
a bacteriocin produced by E. cloacea. The plasmid Clo DF13 encodes gene for cloacin. There 
plasmid encodes 9 nine proteins and the 3 of them are essential for the lethal activity of cloacin.  
They are the cloacin, the immunity protein and the H protein (Elzen et al, 1983).       
The cloacin performs the following actions that are lethal for the sensitive cell; binds to the receptor 
on the surface of the sensitive cell, cleaves 16s rRNA and thus inactivates ribosomes and inhibits 
protein synthesis and causes the pore formation in the sensitive cell that results in the leakage of 
potassium ions and cell death (Elzen et al, 1983). Cloacin also kills K. pneumoniae strains by 
cleaving 16s rRNA (Oudega et al, 1979). In a research study, it was observed that three types of 
klebicins belonging to the group A use the same cell surface receptor as cloacin, the receptor is 
ferric aerobactin and those K. pneumoniae cells that are resistant to cloacin have been found to 
lack those receptors (Cooper et al, 1985).  Cloacin has been reported to have three domains; 
translocation, receptor binding, and cytotoxic (RNase activity) (Elzen et al, 1983). The immunity 
protein binds between translocation and RNase activity domains.       
The sequence provided by mass/spectrometry was matched in BLAST and was found 94% similar 
to the cloacin ribonuclease and the second closest match was colicin E6 that is a tRNAse. When 
the individual domains were match against the sequences in the data bank, all the three domains; 
translocation, receptor binding and cytotoxic were closest to cloacin ribonuclease, the second 
possible match was colicin E6 that has similarity only in translocation and cytotoxic domains but 
not in receptor binding domain that explains colicin using BtuB receptor for attachment with the 
sensitive cell. Colicin E4 and E6 are also known as ribonuclease but they do not directly attack 
rRNA or tRNA but they stop the synthesis of ribosomes (Tomita et al, 2000). This gives one 
possibility that new bacteriocin can also be a homologue of E6 and the mechanism of action inside 
the sensitive cell might be similar (Tomita et al, 2000).       
In the search with individual domains the receptor binding and the cytotoxic domains were highly 
matched with the respective domains of cloacin and with 97 % match and the translocation domain 
was 94 % similar. Klebicin C, B and D have been found with similarities in domains with colicins 
(chapter 1, figure 1) (Chavan et al, 2005). Considering the fact from the past research that cloacin 
and klebicin uses the same cell surface receptor, they both are ribonuclease and the homologous 
sequence search by BLAST matches the sequence with the cloacin give a strong possibility of this 
new bacteriocin to be very similar to cloacin in all three domains.       
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4.1.7.   Conclusion      
This new finding leads to many possible areas for exploring the similarities between cloacin and 
the new bacteriocin. To this stage new bacteriocin uses the same cell surface receptor, for 
attachment and has a very similar cytotoxic domain that means the killing mechanism is the same 
as cloacin. But it is unknown if the victim is rRNA or tRNA, e.g, colicins E4 and E6 have sequence 
homology with colicin E3 but the E4 and E6 target amino acid incorporation and E3 directly 
cleaves 16s rRNA (Tomita et al, 2000). Therefore, if new bacteriocin has sequence homology with 
cloacin, it can have a different mechanism of action inside the cell of attacking RNA or it can have 
a different process of synthesis. The aim of the project was to isolate and identify the bacteriocin 
produced by K. pneumoniae. The aim of the project has been achieved. A new bacteriocin from K. 
pneumoniae has been found, isolated and has been identified as a ribonuclease bacteriocin. But 
this finding is the beginning of many new research work that will help in identifying the physical 
and chemical properties of the new bacteriocin.       
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